Thus a phytoestrogenic nutraceutical with the desirable estrogenic attributes displayed by SM6Met may alleviate menopausal symptoms through ERβ activation, whilst as a positive side effect it might prevent the development of breast cancer through ERα antagonism [42]. Here, ESR1 is linked to breast cancer.